Associated Papers
Structural Analysis of Missense Mutations on the Stability of APOE3 and APOE4.
Anthony M et al.
Genes, 2025
Identification of a founder haplotype of APOE Kyoto variant in lipoprotein glomerulopathy.
Wu H et al.
Clinical Kidney Journal, 2025
40800214 (PubMed )
Supplement: sfaf234_supplemental_file.pdf
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.
Matsunaga A et al.
Journal of Atherosclerosis and Thrombosis, 2025
Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy.
Qin Y et al.
Renal Failure, 2024
A novel apolipoprotein E mutation, ApoE Ganzhou (Arg43Cys), in a Chinese son and his father with lipoprotein glomerulopathy: two case reports.
Wang R et al.
Journal of Medical Case Reports, 2022
Lipoprotein glomerulopathy resulting from compound heterogeneous mutations of APOE gene: A case report.
Li Y et al.
Medicine, 2022
An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy.
Li MS et al.
Frontiers in Medicine, 2022
35602473 (PubMed )
Supplement: Table_1.DOCX
Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
da Silveira-Neto JN et al.
Diagnostic Pathology, 2021
Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.
Yang M et al.
Molecular Genetics & Genomic Medicine, 2020
Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy.
Katsarou M et al.
Journal of Lipid Research, 2018
The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Wu H et al.
Journal of Atherosclerosis and Thrombosis, 2018
Select a paper to view details